← All Sponsors
SPONSOR

Candel Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Prostate Cancer Patients Treated by RadiotherapyProstate Cancer (Adenocarcinoma)
NCT07332000 Phase 2
Recruiting

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Prostate Cancer Patients Treated by Radiotherapy
United States View Trial →